Cervomed to participate in the bio ceo and investor conference

Boston, feb. 21, 2024 (globe newswire) -- cervomed inc. (nasdaq: crvo), a clinical stage company focused on developing treatments for degenerative diseases of the brain, today announced that company's management will present at the bio ceo and investor conference on february 26, 2024, being held in new york, ny and participate in one-on-one investor meetings.

CRVO Ratings Summary

CRVO Quant Ranking